# CDH Investments' Biotech Investments: 23 Startups in Its Portfolio (2026) > The 23 Biotech startups CDH Investments has backed, by stage: $2.0B raised between them. From the rounds we track; updated nightly. Source: https://millionrounds.com/portfolio-maps/cdh-investments-biotech-portfolio (Millionrounds; every figure on the page links to its filing or article) ## Series C and later 7 - [*I* I-Mab](https://millionrounds.com/company/i-mab) - [*CB* Creative Biosciences](https://millionrounds.com/company/creative-biosciences) - [Cloudbreak Therapeutics](https://millionrounds.com/company/cloudbreak-therapeutics) - [Virogin Biotech](https://millionrounds.com/company/virogin-biotech) - [*AT* AusperBio Therapeutics](https://millionrounds.com/company/ausperbio-therapeutics) - [GenFleet Therapeutics](https://millionrounds.com/company/genfleet-therapeutics) - [Qitan Technology](https://millionrounds.com/company/qitan-technology) ## Stage not reported 6 - [BrainCo](https://millionrounds.com/company/brainco) - [Medbanks](https://millionrounds.com/company/medbanks) - [Soyoung](https://millionrounds.com/company/soyoung) - [HitGen](https://millionrounds.com/company/hitgen) - [HemaCell](https://millionrounds.com/company/hemacell) - [RootPath](https://millionrounds.com/company/rootpath) ## Series A 6 - [Spear Bio](https://millionrounds.com/company/spear-bio) - [GemPharmatech](https://millionrounds.com/company/gempharmatech) - [*M* Mengmei](https://millionrounds.com/company/mengmei) - [Innolake Biopharm](https://millionrounds.com/company/innolake-biopharm) - [Ceram Pharmaceuticals](https://millionrounds.com/company/ceram-pharmaceuticals) - [UniXell Biotechnology](https://millionrounds.com/company/unixell-biotechnology) ## Series B 4 - [Harbour BioMed](https://millionrounds.com/company/harbour-biomed) - [AusperBio](https://millionrounds.com/company/ausperbio) - [Singleron Biotechnologies](https://millionrounds.com/company/singleron-biotechnologies) - [Daxiang Biotech](https://millionrounds.com/company/daxiang-biotech) ## Segment by segment ### Series C and later 7 startups · $838M raised - [*I* **I-Mab**](https://millionrounds.com/company/i-mab) China $220M - [*CB* **Creative Biosciences**](https://millionrounds.com/company/creative-biosciences) Creative Biosciences is a biomedical technology company. China $132M - [**Cloudbreak Therapeutics**](https://millionrounds.com/company/cloudbreak-therapeutics) Cloudbreak Therapeutics is a clinical stage biotechnology company United States $130M - [**Virogin Biotech**](https://millionrounds.com/company/virogin-biotech) Virogin Biotech is a clinical-stage immuno-oncology company based in Richmond/Vancouver, British Columbia, Canada. Canada $120M - [*AT* **AusperBio Therapeutics**](https://millionrounds.com/company/ausperbio-therapeutics) United States $120M - [**GenFleet Therapeutics**](https://millionrounds.com/company/genfleet-therapeutics) GenFleet Therapeutics is a biotechnology developer and researcher of molecular pharmaceuticals targeting cancer treatments. China $96M - [**Qitan Technology**](https://millionrounds.com/company/qitan-technology) Qitan Technology is a Developer of a genome sequencing technology. China $20M ### Stage not reported 6 startups · $617M raised - [**BrainCo**](https://millionrounds.com/company/brainco) Brain Co. United States $292M - [**Medbanks**](https://millionrounds.com/company/medbanks) Medbanks develops customized medical service and health care based on self-built medical expert network and drugstore network, pro China $201M - [**Soyoung**](https://millionrounds.com/company/soyoung) 新氧 soyoung is an internet company based out of China. China $60M - [**HitGen**](https://millionrounds.com/company/hitgen) HitGen is provides biological reagents and services to support drug discovery research. China $39M - [**HemaCell**](https://millionrounds.com/company/hemacell) HemaCell is a new cell therapy company to regenerate hematopoietic lineages in vitro, with unique stem cell reprogramming. China $17M - [**RootPath**](https://millionrounds.com/company/rootpath) RootPath is a synthetic biology company dedicated to reducing the cost of gene synthesis and enhancing gene function interrogation. United States $8.4M ### Series A 6 startups · $119M raised - [**Spear Bio**](https://millionrounds.com/company/spear-bio) Spear Bio is a biotechnology startup based in Woburn, Massachusetts, founded in 2021. United States $45M - [**GemPharmatech**](https://millionrounds.com/company/gempharmatech) GemPharmatech Co., Ltd. United States $23M - [*M* **Mengmei**](https://millionrounds.com/company/mengmei) Mengmei is a medical service organization founded by 6 doctors of American Dream Beauty HRC. China $15M - [**Innolake Biopharm**](https://millionrounds.com/company/innolake-biopharm) Innolake Biopharm is a clinical stage biotech company, dedicated to developing innovative medicines against cancer and autoimmune China $14M - [**Ceram Pharmaceuticals**](https://millionrounds.com/company/ceram-pharmaceuticals) Ceram Pharmaceuticals is a biotech firm that uses epigenetics to carry out R&D of drugs and diagnostic treatments for cancer and diseases. China $14M - [**UniXell Biotechnology**](https://millionrounds.com/company/unixell-biotechnology) UniXell Biotechnology is a new-generation cell therapy drug developer, focuses on the development of a new generation of cell therapy drugs. China $7.2M ### Series B 4 startups · $418M raised - [**Harbour BioMed**](https://millionrounds.com/company/harbour-biomed) Harbour BioMed is a clinical stage biopharmaceutical company developing innovative therapeutics in the fields of immuno-oncology. China $190M - [**AusperBio**](https://millionrounds.com/company/ausperbio) AusperBio is a clinical-stage biopharmaceutical company dedicated to advancing treatments for hepatitis B virus (HBV) and developi United States $113M - [**Singleron Biotechnologies**](https://millionrounds.com/company/singleron-biotechnologies) Singleron Biotechnologies is an innovative molecular diagnostic company. China $100M - [**Daxiang Biotech**](https://millionrounds.com/company/daxiang-biotech) Daxiang Biotech is a biotechnology innovator focused on organoid, organ-on-a-chip, and microphysiological system technologies for China $15M **How this map is made.** Every startup here works in Biotech and has raised money in a round we track that names CDH Investments as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026. ## More portfolio maps [All portfolios](https://millionrounds.com/portfolio-maps) [Sector portfolio **CDH Investments' AI portfolio** 13 startups · $3.3B](https://millionrounds.com/portfolio-maps/cdh-investments-ai-portfolio)[Portfolio map **CDH Investments portfolio map** 58 startups · $11B](https://millionrounds.com/portfolio-maps/cdh-investments-portfolio-map)[Investments abroad **CDH Investments' investments in China** 50 startups · $11B](https://millionrounds.com/portfolio-maps/cdh-investments-investments-china)[Co-investors **Who invests with CDH Investments** 42 co-investors](https://millionrounds.com/portfolio-maps/cdh-investments-co-investors)[Sector portfolio **Alameda Research's Web3 & Crypto portfolio** 25 startups · $91M](https://millionrounds.com/portfolio-maps/alameda-research-web3-crypto-portfolio)[Sector portfolio **Saif Partners' Internet portfolio** 16 startups · $3.3B](https://millionrounds.com/portfolio-maps/saif-partners-internet-portfolio) ## Raising from investors like CDH Investments? Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports. [Find investors](https://millionrounds.com/login?join=1&next=/app/investors)[Market maps](https://millionrounds.com/market-maps)